Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 8
2006 8
2007 4
2008 2
2009 4
2010 5
2011 1
2012 6
2013 12
2014 13
2015 15
2016 7
2017 2
2018 4
2019 2
2020 11
2021 8
2022 5
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Endocytosis in cancer and cancer therapy.
Banushi B, Joseph SR, Lum B, Lee JJ, Simpson F. Banushi B, et al. Among authors: simpson f. Nat Rev Cancer. 2023 Jul;23(7):450-473. doi: 10.1038/s41568-023-00574-6. Epub 2023 May 22. Nat Rev Cancer. 2023. PMID: 37217781 Review.
Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies.
Chew HY, De Lima PO, Gonzalez Cruz JL, Banushi B, Echejoh G, Hu L, Joseph SR, Lum B, Rae J, O'Donnell JS, Merida de Long L, Okano S, King B, Barry R, Moi D, Mazzieri R, Thomas R, Souza-Fonseca-Guimaraes F, Foote M, McCluskey A, Robinson PJ, Frazer IH, Saunders NA, Parton RG, Dolcetti R, Cuff K, Martin JH, Panizza B, Walpole E, Wells JW, Simpson F. Chew HY, et al. Among authors: simpson f. Cell. 2020 Mar 5;180(5):895-914.e27. doi: 10.1016/j.cell.2020.02.019. Cell. 2020. PMID: 32142680 Free article.
Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial.
Doig GS, Simpson F, Heighes PT, Bellomo R, Chesher D, Caterson ID, Reade MC, Harrigan PW; Refeeding Syndrome Trial Investigators Group. Doig GS, et al. Among authors: simpson f. Lancet Respir Med. 2015 Dec;3(12):943-52. doi: 10.1016/S2213-2600(15)00418-X. Epub 2015 Nov 18. Lancet Respir Med. 2015. PMID: 26597128 Clinical Trial.
Weaponizing natural killer cells for solid cancer immunotherapy.
Wong JKM, Dolcetti R, Rhee H, Simpson F, Souza-Fonseca-Guimaraes F. Wong JKM, et al. Among authors: simpson f. Trends Cancer. 2023 Feb;9(2):111-121. doi: 10.1016/j.trecan.2022.10.009. Epub 2022 Nov 12. Trends Cancer. 2023. PMID: 36379852 Review.
Therapies for the treatment of onychomycosis.
Gupta AK, Paquet M, Simpson FC. Gupta AK, et al. Among authors: simpson fc. Clin Dermatol. 2013 Sep-Oct;31(5):544-54. doi: 10.1016/j.clindermatol.2013.06.011. Clin Dermatol. 2013. PMID: 24079583 Review.
Investigational drugs for onychomycosis.
Gupta AK, Simpson FC. Gupta AK, et al. Among authors: simpson fc. Expert Opin Investig Drugs. 2014 Jan;23(1):97-106. doi: 10.1517/13543784.2013.840289. Epub 2013 Sep 26. Expert Opin Investig Drugs. 2014. PMID: 24070182 Review.
Laser therapy for onychomycosis.
Gupta AK, Simpson FC. Gupta AK, et al. Among authors: simpson fc. J Cutan Med Surg. 2013 Sep-Oct;17(5):301-7. doi: 10.2310/7750.2012.12060. J Cutan Med Surg. 2013. PMID: 24067848 Review.
111 results